Novel folate binding protein-1 interactions in embryonic orofacial tissue

Life Sciences

Volumn 86, Issue 7-8, 2010, Pages 275-280

  Pisano, M Michele ^a   Bhattacherjee, Vasker ^a   Wong, Leeyean ^b   Finnell, Richard H ^b   Greene, Robert M ^a  

^a UNIVERSITY OF LOUISVILLE   (United States)

^b TEXAS A AND M HEALTH SCIENCE CENTER   (United States)

Author keywords

Bat2d; Embryo; Fibronectin type III containing domain protein; Folate binding protein; Orofacial; Two hybrid screen

Indexed keywords

BINDING PROTEIN; COMPLEMENTARY DNA; FIBRONECTIN TYPE 3 DOMAIN PROTEIN; FOLATE BINDING PROTEIN; FOLATE BINDING PROTEIN 1; FOLIC ACID; GLUTATHIONE TRANSFERASE; PROTEIN BAT2D; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; CELL MEMBRANE TRANSPORT; CONTROLLED STUDY; EMBRYO; EMBRYO DEVELOPMENT; LIPID RAFT; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PALATE; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; TWO HYBRID SYSTEM;

ANIMALS; BIOLOGICAL TRANSPORT; CARRIER PROTEINS; EMBRYO, MAMMALIAN; EMBRYONIC DEVELOPMENT; FOLIC ACID; MEMBRANE MICRODOMAINS; MICE; RECEPTORS, CELL SURFACE;

EID: 75549084906     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lfs.2009.12.011     Document Type: Article

References (41)

1. Anderson R.G., Kamen B.A., Rothberg K.G., Lacey S.W. Potocytosis: sequestration and transport of small molecules by caveolae. Science 1992, 255:410-411.
2. Antony A.C., Hansen D.K. Hypothesis: folate-responsive neural tube defects and neurocristopathies. Teratology 2000, 62:42-50.
3. Armstrong P.B., Armstrong M.T. Intercellular invasion and the organizational stability of tissues: a role for fibronectin. Biochimica et Biophysica Acta 2000, 1470:9-20.
4. Ausubel F.M., Brent R., Kingston R.E., Moore D.D., Seidman J.G., Smith J.A., Struhl K. Current Protocols in Molecular Biology. 1994, Wiley, New York.
5. Badovinac R.L., Werler M.M., Williams P.L., Kelsey K.T., Hayes C. Folic acid-containing supplement consumption during pregnancy and risk for oral clefts: a meta-analysis. Birth Defects Reserach A Clinical Molecular Teratol 2007, 79:8-15.
6. Banerji J., Sands J., Strominger J.L., Spies T. A gene pair from the human major histocompatibility complex encodes large proline-rich proteins with multiple repeated motifs and a single ubiquitin-like domain. Proceedings of the National Acadademy of Sciences U S A 1990, 87:2374-2378.
7. Barber R.C., Bennett G.D., Greer K.A., Finnell R.H. Expression patterns of folate binding proteins one and two in the developing mouse embryo. Molecular Genetics and Metabolism 1999, 66:31-39.
8. Barber R.C., Lammer E.J., Shaw G.M., Greer K.A., Finnell R.H. The role of folate transport and metabolism in neural tube defect risk. Molecular Genetics and Metabolism 1999, 66:1-9.
9. Birn H., Selhub J., Christensen E.I. Internalization and intracellular transport of folate-binding protein in rat kidney proximal tubule. American Journal of Physiology 1993, 264:C302-C310.
10. Birn H., Zhai X., Holm J., Hansen S.I., Jacobsen C., Christensen E.I., Moestrup S.K. Megalin binds and mediates cellular internalization of folate binding protein. Federation of European Biochemical Societies Journal 2005, 272:4423-4430. Sep.
11. Botto L.D., Yang Q. 5, 10-Methylenetetrahydrofolate reductase gene variants and congenital anomalies: a HuGE review. American Journal of Epidemiology 2000, 151:862-877.
12. Brigle K.E., Westin E.H., Houghton M.T., Goldman I.D. Characterization of two cDNAs encoding folate-binding proteins from L1210 murine leukemia cells. Increased expression associated with a genomic rearrangement. Journal of Biological Chemistry 1991, 266:17243-17249.
13. Brigle K.E., Spinella M.J., Westin E.H., Goldman I.D. Increased expression and characterization of two distinct folate binding proteins in murine erythroleukemia cells. Biochemical Pharmacology 1994, 47:337-345.
14. Calaycay J., Pande H., Lee T., Borsi L., Siri A., Shively J.E., Zardi L. Primary structure of a DNA- and heparin-binding domain (Domain III) in human plasma fibronectin. Journal of Biological Chemistry 1985, 260:12136-12141.
15. Chai Y., Maxson R.E. Recent advances in craniofacial morphogenesis. Developmental Dynamics 2006, 235:2353-2375.
16. De Marco P., Moroni A., Merello E., de Franchis R., Andreussi L., Finnell R.H., Barber R.C., Cama A., Capra V. Folate pathway gene alterations in patients with neural tube defects. American Journal of Medical Genetics 2000, 95:216-223.
17. Finnell R.H., Greer K.A., Barber R.C., Piedrahita J.A. Neural tube and craniofacial defects with special emphasis on folate pathway genes. Critical Review of Oral Biology and Medicine 1998, 9:38-53.
18. Geerts D., Fontao L., Nievers M.G., Schaapveld R.Q., Purkis P.E., Wheeler G.N., Lane E.B., Leigh I.M., Sonnenberg A. Binding of integrin alpha6beta4 to plectin prevents plectin association with F-actin but does not interfere with intermediate filament binding. Journal of Cell Biology 1999, 147:417-434.
19. Henderson G.I., Perez T., Schenker S., Mackins J., Antony A.C. Maternal-to-fetal transfer of 5-methyltetrahydrofolate by the perfused human placental cotyledon: evidence for a concentrative role by placental folate receptors in fetal folate delivery. Journal of Laboratory and Clinical Medicine 1995, 126:184-203.
20. Huang W.C., Taylor S., Nguyen T.B., Tomaszewski J.E., Libertino J.A., Malkowicz S.B., McGarvey T.W. KIAA1096, a gene on chromosome 1q, is amplified and overexpressed in bladder cancer. DNA Cell Biology 2002, 21:707-715.
21. Kamen B.A., Wang M.T., Streckfuss A.J., Peryea X., Anderson R.G. Delivery of folates to the cytoplasm of MA104 cells is mediated by a surface membrane receptor that recycles. Journal of Biological Chemistry 1988, 263:13602-13609.
22. Lacey S.W., Sanders J.M., Rothberg K.G., Anderson R.G., Kamen B.A. Complementary DNA for the folate binding protein correctly predicts anchoring to the membrane by glycosyl-phosphatidylinositol. Journal of Clinical Investigation 1989, 84:715-720.
23. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970, 227:680-685.
24. Loffredo L.C., Souza J.M., Freitas J.A., Mossey P.A. Oral clefts and vitamin supplementation. Cleft Palate-Craniofacial Journal 2001, 38:76-83.
25. Miotti S., Bagnoli M., Tomassetti A., Colnaghi M.I., Canevari S. Interaction of folate receptor with signaling molecules lyn and G(alpha)(i-3) in detergent-resistant complexes from the ovary carcinoma cell line IGROV1. Journal of Cell Science 2000, 113:349-357.
26. Miyamoto S., Katz B.Z., Lafrenie R.M., Yamada K.M. Fibronectin and integrins in cell adhesion, signaling, and morphogenesis. Annals of the New York Acadademy of Science 1998, 857:119-129.
27. Mukhopadhyay P., Greene R.M., Zacharias W., Weinrich M.C., Singh S., Young W.W., Pisano M.M. Developmental gene expression profiling of mammalian, fetal orofacial tissue. Birth Defects Research A - Clinical and Molecular Teratology 2004, 70:912-926.
28. Newgreen D., Thiery J.P. Fibronectin in early avian embryos: synthesis and distribution along the migration pathways of neural crest cells. Cell and Tissue Research 1980, 211:269-291.
29. Piedrahita J.A., Oetama B., Bennett G.D., van Waes J., Kamen B.A., Richardson J., Lacey S.W., Anderson R.G., Finnell R.H. Mice lacking the folic acid-binding protein Folbp1 are defective in early embryonic development. Nature Genetics 1999, 23:228-232.
30. Scanlon K.S., Ferencz C., Loffredo C.A., Wilson P.D., Correa-Villasenor A., Khoury M.J., Willett W.C. Preconceptional folate intake and malformations of the cardiac outflow tract. Baltimore-Washington Infant Study Group. Epidemiology 1998, 9:95-98.
31. Shaw G.M., Lammer E.J., Wasserman C.R., O'Malley C.D., Tolarova M.M. Risks of orofacial clefts in children born to women using multivitamins containing folic acid periconceptionally. Lancet 1995, 346:393-396.
32. Singh G.D., Johnston J., Ma W., Lozanoff S. Cleft palate formation in fetal Br mice with midfacial retrusion: tenascin, fibronectin, laminin, and type IV collagen immunolocalization. Cleft Palate-Craniofacial Journal 1998, 35:65-76.
33. Sun N.N., Fastje C.D., Wong S.S., Sheppard P.R., Macdonald S.J., Ridenour G., Hyde J.D., Witten M.L. Dose-dependent transcriptome changes by metal ores on a human acute lymphoblastic leukemia cell line. Toxicology and Industrial Health 2003, 19:157-163.
34. Tolarova M. Periconceptional supplementation with vitamins and folic acid to prevent recurrence of cleft lip. Lancet 1982, 2:217.
35. Tolarova M., Harris J. Reduced recurrence of orofacial clefts after periconceptional supplementation with high-dose folic acid and multivitamins. Teratology 1995, 51:71-78.
36. Wagner C. Biochemical role of folate in cellular metabolism 1995, Marcel Decker, New York.
37. Wang J., Gunning W., Kelley K.M., Ratnam M. Evidence for segregation of heterologous GPI-anchored proteins into separate lipid rafts within the plasma membrane. Journal of Membrane Biology 2002, 189:35-43.
38. Warner D.R., Horn K.H., Mudd L., Webb C.L., Greene R.M., Pisano M.M. PRDM16/MEL1: a novel Smad binding protein expressed in murine embryonic orofacial tissue. Biochimica et Biophysica Acta 2007, 1773:814-820.
39. Werler M.M., Hayes C., Louik C., Shapiro S., Mitchell A.A. Multivitamin supplementation and risk of birth defects. American Journal of Epidemiology 1999, 150:675-682.
40. Yang T., Yin W., Derevyanny V.D., Moore L.A., Longo F.M. Identification of an ectodomain within the LAR protein tyrosine phosphatase receptor that binds homophilically and activates signalling pathways promoting neurite outgrowth. European Journal of Neuroscience 2005, 22:2159-2170.
41. Zabeau L., Defeau D., Iserentant H., Vandekerckhove J., Peelman F., Tavernier J. Leptin receptor activation depends on critical cysteine residues in its fibronectin type III subdomains. Journal of Biological Chemistry 2005, 280:22632-22640.